为解决慢性乙型肝炎(CHB)治疗中肝细胞内HBV DNA异质性检测难题，研究人员开发了单细胞感染检测PCR(scID-PCR)技术。该技术通过微滴封装单细胞并同步检测β-actin和cccDNA，实现了单细胞分辨率下HBV阳性细胞的精准定量。研究在细胞模型和临床肝活检样本中验证了方法 ...

Abbott announced that the FDA has approved its RealTime HBV assay for measuring the amount of hepatitis B virus (HBV) in human plasma or serum from individuals chronically infected with HBV. The ...

Assay can be used with the Abbott m2000 system to understand response to treatment. Abbott received approval from the FDA to market the Abbott RealTime HBV assay for quantitation of HBV in plasma or ...

Real-time PCR or quantitative PCR (Polymerase Chain Reaction) is an advancement of the standard PCR technique, which enables continuous monitoring of the reaction and collection of data in real time.

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the ...

The polymerase chain reaction (PCR), invented about three decades ago, soon entered mainstream use thanks to an ongoing series of refinements. One particularly important refinement, introduced about ...

Background and Aim: Long-term lamivudine treatment for chronic hepatitis B virus (HBV) infection induces the emergence of lamivudine resistant HBV YMDD mutant strains. The aim of the present study was ...